Refining the interpretation of drug survival and safety in VEXAS syndrome: the importance of competing risks and exposure time. Comment on the article by Eviatar et al
Disclosure Form Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Authors
- Shenglong Li (ORCID: https://orcid.org/0000-0003-2244-1184)
- Yi Pei (ORCID: https://orcid.org/0000-0002-9413-504X)
- Runze Jiang (ORCID: https://orcid.org/0000-0002-1442-3165)
Institutions
- Liaoning University of Traditional Chinese Medicine (CN)
- Liaoning Cancer Hospital & Institute (CN)
- China Medical University (CN)
Publication Details
- Journal
- Arthritis & Rheumatology
- Published
- 2025-12-09
- DOI
- https://doi.org/10.1002/art.70012
- Primary Topic
- Otitis Media and Relapsing Polychondritis
- Type
- article
- Field-Weighted Citation Impact
- 0.00